Acelyrin News

Analysts Offer Insights on Healthcare Companies: ACELYRIN, INC. (SLRN), Cabaletta Bio (CABA) and Mersana Therapeutics (MRSN)

TipRanksNov 15 05:32 ET

Vikram Purohit's Hold Rating on ACELYRIN, INC.: Awaiting Key Data and Trial Progress for Future Stock Movement

TipRanksNov 15 05:32 ET

Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Maintains Target Price $6

Moomoo NewsNov 15 05:31 ET

ACELYRIN Is Maintained at Neutral by HC Wainwright & Co.

Dow JonesNov 14 13:42 ET

Acelyrin Analyst Ratings

BenzingaNov 14 13:33 ET

TD Cowen Maintains Acelyrin(SLRN.US) With Buy Rating

Moomoo NewsNov 14 08:34 ET

Piper Sandler Maintains Acelyrin(SLRN.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsNov 14 08:34 ET

A Quick Look at Today's Ratings for Acelyrin(SLRN.US), With a Forecast Between $8 to $20

Moomoo NewsNov 14 08:06 ET

Acelyrin's Phase 3 Trial Progress and Uncertainties Lead to Hold Rating

TipRanksNov 14 06:20 ET

ACELYRIN Is Maintained at Overweight by Wells Fargo

Dow JonesOct 16 11:52 ET

Acelyrin Analyst Ratings

BenzingaOct 16 11:43 ET

Wells Fargo Maintains Acelyrin(SLRN.US) With Buy Rating, Raises Target Price to $15

Moomoo NewsOct 16 06:31 ET

Piper Sandler Maintains Acelyrin(SLRN.US) With Buy Rating, Maintains Target Price $20

Moomoo NewsSep 25 07:31 ET

ACELYRIN, INC. (SLRN) Receives a Buy From Piper Sandler

TipRanksSep 25 07:29 ET

Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Maintains Target Price $6

Moomoo NewsAug 20 08:33 ET

ACELYRIN Price Target Cut to $6.00/Share From $13.00 by Morgan Stanley

Dow JonesAug 19 13:09 ET

Acelyrin Analyst Ratings

BenzingaAug 19 13:01 ET

Morgan Stanley Maintains Acelyrin(SLRN.US) With Hold Rating, Cuts Target Price to $6

Moomoo NewsAug 19 09:31 ET

ACELYRIN, INC.: Hold Rating Maintained Amid Strategic Pipeline Shift and Extended Cash Runway

TipRanksAug 19 08:47 ET

A Quick Look at Today's Ratings for Acelyrin(SLRN.US), With a Forecast Between $6 to $20

Moomoo NewsAug 15 09:01 ET